Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad

Area of Science:

• Nephrology
• Cardiology
• Metabolic Diseases

Background:

• Metabolic syndrome (MS) and chronic kidney disease (CKD) are prevalent global health concerns with significant morbidity and mortality.
• The intricate relationship and causality between MS and CKD remain incompletely understood.
• There is a need for further investigation into prophylactic and therapeutic strategies for patients with both conditions.

Purpose of the Study:

• To critically review the current clinical evidence linking MS to renal and cardiovascular diseases.
• To elucidate the pathophysiologic mechanisms underlying the association between MS and kidney disease.
• To discuss current and potential treatment options for managing MS in the context of CKD.

Main Methods:

• Systematic review of existing clinical evidence.
• Analysis of pathophysiologic mechanisms.
• Evaluation of current therapeutic interventions.

Main Results:

• Evidence associates MS with increased risk and progression of renal and cardiovascular diseases.
• Pathophysiologic links include inflammation, oxidative stress, and endothelial dysfunction.
• Current treatment focuses on managing individual MS components and CKD progression.

Conclusions:

• MS is a significant risk factor for CKD and cardiovascular complications.
• Understanding the mechanisms is crucial for developing targeted therapies.
• Integrated management strategies are essential for improving outcomes in patients with MS and CKD.